Human use evidence hub / HBOC-201 & Hemopure

Human-use oxygen therapeutics.
Evidence in context.

Explore human clinical publications, reviews and translational studies by therapeutic direction, while keeping human evidence clearly separated from animal, veterinary and analytical research.

ClinicalTrials.gov

Electronically registered clinical studies

Hemopure / HBOC-201

9ClinicalTrials.gov records
Open registry →
198Publication recordsUnique records in this application view10Therapeutic areasRecorded catalogue groups81Author institutionsIndexed author affiliations96JournalsNormalized journal labels
Browse the evidence

Human-use Directions

198 total records

Select a therapeutic direction to open matching publications.

Counts are catalogue assignments, not conclusions about efficacy, safety or regulatory status.

How to interpret these numbers

Human clinical, preclinical, analytical, review and pending-classification records remain separately labelled. A publication may support scientific context without establishing a clinical claim.

Single-source records remain flagged until verified against an original identifier or full text.

Evidence boundary

Human evidence stays human.
Translational evidence stays labelled.

Preclinical evidence supporting human development74 publication records →
Human clinical publications
45
Translational preclinical publications
74
01 / Directions

Start with the clinical question.

Browse cardiac ischemia, resuscitation, severe anemia, trauma, surgery, critical care and oncology evidence.

Browse directions →
02 / Regulation

Read access in context.

Review the HBOC-201 expanded-access study record, FDA pathway and IND requirements without confusing access with marketing approval.

FDA US Expanded Access →
03 / People & sources

Follow the work to its origin.

Search 81 indexed author institutions and 96 normalized journal labels, then open available PubMed, DOI and original publication links.

Search the evidence →

This section is a structured evidence map. Publication inclusion does not establish efficacy, regulatory approval or a clinical recommendation. Historical HBOC, HBOC-201 and Hemopure terminology is retained for accurate scientific discovery.